You have Guest access.
Log In
Published in partnership with the
European Association for the Study of Diabetes
Research Letter
W. L. Suarez-Pinzon, G. S. Cembrowski and A. Rabinovitch
Journal Article
Suppressor of cytokine signalling-3 expression inhibits cytokine-mediated destruction of primary mouse and rat pancreatic islets and delays allograft rejection
S. G. Rønn, A. Börjesson, C. Bruun, P. E. Heding and H. Frobøse, et al.
Diabetologia, 2008, Volume 51, Number 10, Pages 1873-1882
Presence of residual beta cells and co-existing islet autoimmunity in the NOD mouse during longstanding diabetes: a combined histochemical and immunohistochemical study
Shiva Reddy, Ryan Chau Chia Chai, Jessica Astrid Rodrigues, Tzu-Hsuan Hsu and Elizabeth Robinson
Journal of Molecular Histology, 2008, Volume 39, Number 1, Pages 25-36
Pathology of the pancreas and other organs in the diabetic LEW.1AR1/Ztm- iddm rat, a new model of spontaneous insulin-dependent diabetes mellitus
Anne Jörns, Birgit Kubat, Markus Tiedge, Dirk Wedekind and Hans-Jürgen Hedrich, et al.
Virchows Archiv, 2004, Volume 444, Number 2, Pages 183-189
Facilitating Physiologic Self-Regeneration: A Step Beyond Islet Cell Replacement
Pleunie P. M. Rood, Rita Bottino, A. N. Balamurugan, Yong Fan and David K. C. Cooper, et al.
Pharmaceutical Research, 2006, Volume 23, Number 2, Pages 227-242
Loss of islet sympathetic nerves and impairment of glucagon secretion in the NOD mouse: relationship to invasive insulitis
G. J. Taborsky, Q. Mei, D. J. Hackney, D. P. Figlewicz and R. LeBoeuf, et al.
Diabetologia, 2009, Volume 52, Number 12, Pages 2602-2611
Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes
T. B. Bödvarsdóttir, K. D. Hove, C. F. Gotfredsen, L. Pridal and A. Vaag, et al.
Diabetologia, 2010, Volume 53, Number 10, Pages 2220-2223
Are Sulfonylureas Less Desirable Than DPP-4 Inhibitors as Add-on to Metformin in the Treatment of Type 2 Diabetes?
Bo Ahrén
Current Diabetes Reports, 2011, Volume 11, Number 2, Pages 83-90
The evolving place of incretin-based therapies in type 2 diabetes
Baptist Gallwitz
Pediatric Nephrology, 2010, Volume 25, Number 7, Pages 1207-1217
Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents
C. Gysemans, K. Stoffels, A. Giulietti, L. Overbergh and M. Waer, et al.
Diabetologia, 2003, Volume 46, Number 8, Pages 1115-1123
Destruction of conditional insulinoma cell lines in NOD mice: A role for autoimmunity
P. Cattan, D. Rottembourg, S. Cottet, I. Tardivel and P. Dupraz, et al.
Diabetologia, 2003, Volume 46, Number 4, Pages 504-510
Keywords Dipeptidyl peptidase-4 - Gastrin - Glucagon-like peptide-1 - NOD mice - Proton pump inhibitor - Type 1 diabetes
Frequently asked questions General info on journals and books Send us your feedback Impressum Contact us
© Springer, Part of Springer Science+Business Media Privacy, Disclaimer, Terms & Conditions, and Copyright Info